PepCalcs
    Back to Library

    Chonluten

    Research Use OnlyPreclinical / Russian early clinical research. Not FDA approved.

    Chonluten

    Description

    A respiratory bioregulator peptide supporting bronchial mucosa and lung function. Part of comprehensive respiratory health protocols.

    Dose:2 mg
    Frequency:30 days in a row, 2-3x per year
    Administration Method: SQ
    CategoryBioregulator
    Half-LifeVery short (minutes); typical of Khavinson short peptides.

    Overview

    Chonluten, also known as tripeptide T-34, is a peptide bioregulator derived from lung tissue. It is primarily used to support respiratory health by promoting the repair and regeneration of lung tissue and is designed to improve lung capacity, reduce inflammation, and enhance the overall health of the respiratory tract.

    Mechanism of Action

    Chonluten is classified as a potential gene expression peptide. It influences gene expression related to lung repair and regeneration, helping restore normal lung function. It may also modulate genes by interacting with DNA at promoter, suppressor, and other control regions.

    Benefits

    • •Respiratory health
    • •Bronchial support
    • •Mucosa health
    • •Longevity

    Reported Side Effects

    • •Limited human safety data
    • •Possible injection site reactions

    Scientific References

    Related Bioregulator Peptides